Aytu BioScience (NASDAQ: AYTU) reported Q4 EPS of $0.00, $0.28 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $16.1 million versus the consensus estimate of $12.28 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.